Holistics evidence
Essential oil inhalation is a holistic and economic treatment for the alleviation of anxiety. Whether this effect is of a psychological or physiological basis has been in dispute since the beginnings of ‘modern’ medicine. Many would argue that any effects felt are simply psychological, a ‘placebo’ effect, as if the individual believes the treatment will aid them it does.
Essential oil inhalation is a holistic and economic treatment for the alleviation of anxiety. Whether thiseffect is of a psychological or physiological basis has been in dispute since the beginnings of ‘modern’medicine. Many would argue that any effects felt are simply psychological, a ‘placebo’ effect, as if theindividual believes the treatment will aid them it does.
Essential oils are volatile liquids composed mainly of terpenes, derived from aromatic plant material bysteam distillation or mechanical expression1. Commonly used in medicine up until the 20th century, post-20th century they became confined to usage as preservatives and flavour enhancers.However, a group of researchers in China2 has identified evidence that there may indeed be aphysiological effect from the inhalation of essential oils. The scientists identified a global change inthe metabolic profile of rats exposed to a prepared mixture of Lavandula angustifolia (lavender), Salviasclarea (clary sage), Santalum album(sandlewood) and Citrus sinensis (orange fruit). The treated rats wereexposed for a period of ten days to the aroma and then the behavioural effects tested by the elevatedplus maze (EPM) test. The EPM test is well-documented in the testing of drugs designed for the treatmentof stress-related disorders.
The metabolite profile of the rats was measured by analysing the global levels of compounds withinbrain tissue and urine samples, comparing the metabolic profiles of treated and untreated rats. Gaschromatography coupled to time–of–flight mass spectroscopy (GC–TOF-MS) was used to identifycompound levels differentially expressed following exposure to the prepared aromas.The rats exposed to the aroma experienced weight gain and experienced a greater level of calmcompared with control rats when tested. It was found that there were 50 metabolites differentiallyexpressed in the brain tissue compared with 17 metabolites in the urine samples. There were alsolower levels of neurotransmitter and carbohydrates within the braintissue following aroma exposure compared to controls. Thisindicated a change in the levels of metabolites in the brain, coconcurrentwith an increased level of calm.It is hoped that in the future, that this research will highlight newtargets for the development of drugs aimed at the treatment ofanxiety‑related disorders and that the mechanistic understanding maybe further elucidated. However, further study is required tovalidate the findings in humans.
1. National Cancer Institute (USA), (www.cancer.gov).
2. Guoxian Xie et al, PLOS ONE, 7(9), (2012).
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
